We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Visp

News List

Lonza Announces Expansion Plans for Next-Generation Mammalian Manufacturing Facilities in Visp (CH) and Portsmouth (US) americanpharmaceuticalreview
May 07, 2021
Lonza has announced significant investments to expand its mammalian drug substance manufacturing facilities in Visp (CH) and Portsmouth (US).
Lonza to Build Small Molecule Manufacturing Complex in Visp contractpharma
April 25, 2021
Lonza, a contract development and manufacturing organization (CDMO) partner to the biopharma industry, is investing CHF 200 million (~$220mn) in the construction of a new small molecule manufacturing complex at its Visp site in Switerland.
Swissfillon Completes Successful FDA Inspection contractpharma
May 16, 2019
The production site in Visp was assessed by FDA between April 15 and 24.